Teva Pharmaceutical Industries Limited's Suppliers recorded an increase in sales by 1.12 % year on year in Q2 2026, from the previous quarter, sales fell by -0.7 %, Teva Pharmaceutical Industries Limited's cost of sales deteriorated by -4.1 % year on year, relative to one quarter ago cost of sales fell by -1.09 % in Q2.
Teva Pharmaceutical Industries Limited's Suppliers recorded an increase in sales by 1.12 % year on year in Q2 2026, from the previous quarter, sales fell by -0.7 %, Teva Pharmaceutical Industries Limited's cost of sales deteriorated by -4.1 % year on year, compare to one quarter ago cost of sales fell by -1.09 % in Q2.
Teva Pharmaceutical Industries Limited's Comment on Supply Chain
The company procures raw materials and supplies for pharmaceutical production mainly from the open market, with some materials sourced from single or sole suppliers when necessary. To manage supply risks, the company employs inventory management and alternative sourcing strategies. A portion of active pharmaceutical ingredients (APIs) is produced in its 13 manufacturing facilities, while additional APIs are purchased from suppliers in Europe, Asia, and the Americas. The company maintains a supplier audit program to ensure compliance with regulatory standards. Its API facilities adhere to current Good Manufacturing Practice (cGMP) requirements and undergo regular inspections by the FDA, European regulatory agencies, and other authorities.
Teva Pharmaceutical Industries Limited's Comment on Supply Chain
The company procures raw materials and supplies for pharmaceutical production mainly from the open market, with some materials sourced from single or sole suppliers when necessary. To manage supply risks, the company employs inventory management and alternative sourcing strategies. A portion of active pharmaceutical ingredients (APIs) is produced in its 13 manufacturing facilities, while additional APIs are purchased from suppliers in Europe, Asia, and the Americas. The company maintains a supplier audit program to ensure compliance with regulatory standards. Its API facilities adhere to current Good Manufacturing Practice (cGMP) requirements and undergo regular inspections by the FDA, European regulatory agencies, and other authorities.
TEVA's Suppliers recorded a net loss
Suppliers recorded net loss
TEVA's Suppliers recorded a net loss
Suppliers recorded net loss
Teva Pharmaceutical Industries Limited's Suppliers Sales Growth
in Q2 2026 by Industry
Sources:
Teva Pharmaceutical Industries Limited's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Teva Pharmaceutical Industries Limited’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
0.59 %